目的 系統(tǒng)評(píng)價(jià)中藥注射液（注射用丹參多酚酸、丹紅注射液、疏血通注射液、銀杏二萜內(nèi)酯葡胺注射液、銀杏內(nèi)酯注射液）聯(lián)合化學(xué)藥治療急性缺血性腦卒中的有效性和安全性。方法 計(jì)算機(jī)檢索中國(guó)學(xué)術(shù)期刊全文數(shù)據(jù)庫(kù)（CNKI）、萬(wàn)方數(shù)據(jù)知識(shí)服務(wù)平臺(tái)（Wanfang Data）、維普中文期刊全文數(shù)據(jù)庫(kù)（VIP）、中國(guó)生物醫(yī)學(xué)文獻(xiàn)數(shù)據(jù)庫(kù)（CBM）、美國(guó)生物醫(yī)學(xué)期刊文獻(xiàn)數(shù)據(jù)庫(kù)（PubMed）、荷蘭醫(yī)學(xué)文摘數(shù)據(jù)庫(kù)（Embase）、循證醫(yī)學(xué)圖書館（Cochrane Library）、美國(guó)引文數(shù)據(jù)庫(kù)（Web of Science），檢索時(shí)間從建庫(kù)至2023年5月31日，全面收集相關(guān)臨床隨機(jī)對(duì)照試驗(yàn)（RCT），使用Cochrane系統(tǒng)評(píng)價(jià)手冊(cè)進(jìn)行納入研究的質(zhì)量評(píng)價(jià)，采用R 4.0.5和Stata 16軟件進(jìn)行網(wǎng)狀Meta分析。結(jié)果 共納入72項(xiàng)研究，共納入7 343例患者，涉及5種中藥注射劑。網(wǎng)狀Meta分析結(jié)果顯示：在臨床有效率方面，注射用丹參多酚酸、丹紅注射液、疏血通注射液、銀杏二萜內(nèi)酯葡胺注射液、銀杏內(nèi)酯注射液聯(lián)合化學(xué)藥的臨床有效率均高于化學(xué)藥對(duì)照組，累積概率排序?yàn)槭柩ㄗ⑸湟海瘜W(xué)藥（89.36%）＞注射用丹參多酚酸＋化學(xué)藥（87.25%）＞丹紅注射液＋化學(xué)藥（54.14%）＞銀杏內(nèi)酯注射液＋化學(xué)藥（44.48%）＞銀杏二萜內(nèi)酯葡胺注射液＋化學(xué)藥（24.77%）＞化學(xué)藥（0.0%）；在降低美國(guó)國(guó)立衛(wèi)生研究院卒中量表（NIHSS）評(píng)分方面，注射用丹參多酚酸、丹紅注射液、疏血通注射液、銀杏二萜內(nèi)酯葡胺注射液、銀杏內(nèi)酯注射液聯(lián)合化學(xué)藥的NIHSS評(píng)分均低于化學(xué)藥對(duì)照組，累積概率排序?yàn)榈ぜt注射液＋化學(xué)藥（89.63%）＞疏血通注射液＋化學(xué)藥（71.44%）＞注射用丹參多酚酸＋化學(xué)藥（65.19%）＞銀杏內(nèi)酯注射液＋化學(xué)藥（50.41%）＞銀杏二萜內(nèi)酯葡胺注射液＋化學(xué)藥（23.21%）＞化學(xué)藥（0.00%）；在提高日常生活能力量表（BI）評(píng)分方面，注射用丹參多酚酸、丹紅注射液、疏血通注射液、銀杏二萜內(nèi)酯葡胺注射液、銀杏內(nèi)酯注射液聯(lián)合化學(xué)藥的BI評(píng)分均高于化學(xué)藥對(duì)照組，累積概率排序?yàn)殂y杏二萜內(nèi)酯葡胺注射液＋化學(xué)藥（81.33%）＞疏血通注射液＋化學(xué)藥（71.54%）＞丹紅注射液＋化學(xué)藥（64.85%）＞注射用丹參多酚酸＋化學(xué)藥（51.81%）＞銀杏內(nèi)酯注射液＋化學(xué)藥（30.44%）＞化學(xué)藥（0.00%）。共有40項(xiàng)研究報(bào)告了不良反應(yīng)，其中19項(xiàng)研究報(bào)告未出現(xiàn)不良反應(yīng)，其余均無(wú)嚴(yán)重不良反應(yīng)，已報(bào)告的不良反應(yīng)類型均為常見不良反應(yīng)類型，直接Meta分析結(jié)果表明這5種中藥注射液聯(lián)合化學(xué)藥的不良反應(yīng)率與化學(xué)藥不良反應(yīng)率比較，無(wú)統(tǒng)計(jì)學(xué)差異。結(jié)論 5種中藥注射液聯(lián)合化學(xué)藥治療急性缺血性腦卒中均可提高臨床有效率、降低NIHSS評(píng)分和提高BI評(píng)分，提高臨床有效率以疏血通注射液和注射用丹參多酚酸有優(yōu)勢(shì)，丹紅注射液和銀杏二萜內(nèi)酯葡胺注射液在降低NIHSS評(píng)分和提高BI評(píng)分上有優(yōu)勢(shì)。受納入研究的質(zhì)量等局限性，該研究結(jié)論仍需更多高質(zhì)量RCT試驗(yàn)進(jìn)一步證實(shí)。

Objective To evaluate the efficacy and safety of traditional Chinese medicine injections [Salvianolic Acids for Injection (SAFI), Danhong Injection (DH), Shuxuetong Injection (SXT), Ginkgo Diterpene Lactone Meglumine Injection (YXETNZ), Ginkgolide Injection (YXNZ) ] combined with western medicine in the treatment of acute ischemic stroke. Methods Databases including CNKI, Wanfang Data, VIP, CBM, PubMed, Embase, the Cochrane library, and Web of Science were searched to collect randomized controlled trials from the date of establishment to May 31, 2023. ReviewManager 5.3 software was used to make studies quality bias. Network Meta-analysis was performed by R 4.0.5 and Stata 16 software. Results A total of 72 RCTs were included, with a total sample size of 7343 cases. Salvianolic Acids for Injection combined with chemical drugs (SAFI+CM), Danhong Injection combined with chemical drugs (DH+CM), Shuxuetong Injection combined with chemical drugs (SXT+CM), Ginkgo Diterpene Lactone Meglumine Injection combined with chemical drugs (YXETNZ+CM), Ginkgolide Injection combined with chemical drugs (YXNZ+CM) are five interventions. Network Meta-analysis showed that SAFI+CM, DH+CM, SXT+CM, YXETNZ+CM, YXNZ+CM could improve clinical efficiency, and the rank of cumulative probability was SXT+CM(89.36%)＞SAFI+CM (87.25%)＞DH+CM (54.14%)＞YXNZ+CM (44.48%)＞YXETNZ+CM (24.77%)＞CM (0.00%). SAFI+CM, DH+CM, SXT+CM, YXETNZ+CM, YXNZ+CM could reduce NIHSS scores, and the rank of cumulative probability was DH+CM (89.63%)＞SXT+CM (71.44%)＞SAFI+CM (65.19%)＞YXNZ+CM (50.41%)＞YXETNZ+CM (23.21%)＞CM (0.00%). SAFI+ CM, DH+CM, SXT+CM, YXETNZ+CM, YXNZ+CM could improve BI index, and the rank of cumulative probability was YXETNZ+CM (81.33%)＞SXT+CM (71.54%)＞DH+CM (64.85%)＞SAFI+CM (51.81%)＞YXNZ+CM (30.44%)＞CM (0.00%). A total of 40 studies reported adverse reactions, of which 19 studies reported no reactions. Others were no serious adverse reactions. The reported types of adverse reactions are all common types of adverse reactions. Meta-analysis results show that there is no statistically significant difference in the incidence of adverse reactions between the combination of these five traditional Chinese medicine injections and chemical drugs. Conclusion Five traditional Chinese medicine injections combined with chemical drugs in the treatment of acute ischemic stroke can improve the clinical efficiency, without serious adverse reactions. SXT+CM and SAFI+ CM have an improved effect on the total effective rate, while DH+CM and YXETNZ+CM show advantages in NIHSS score and Barthel index. The above research results still need to be verified by more multicenter, large sample and double-blind randomized controlled trials.

R286.1

河北省醫(yī)學(xué)研究重點(diǎn)課題計(jì)劃項(xiàng)目（20181487）